What makes developing recombinant Adeno-Associated Viruses (rAAVs), Chimeric Antigen Receptor T Cells (CAR-Ts), enhanced Natural Killer Cells (iNKs), or modified T-cell receptors (TCRs) so challenging? The need to streamline design, generation, and testing of these complicated modalities. The vast amount of complex data that needs to be stored, analyzed, and shared across the entire R&D process. The need for data traceability and data protection.
This is where Genedata comes in.